Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
6,540.00
+140.00 (2.19%)
At close: Nov 13, 2026
| Market Cap | 74.40B +11.8% |
| Revenue (ttm) | 86.82B +7.2% |
| Net Income | 6.42B -44.1% |
| EPS | 555.26 -44.1% |
| Shares Out | 11.38M |
| PE Ratio | 11.78 |
| Forward PE | n/a |
| Dividend | 190.00 (2.91%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 28,433 |
| Open | 6,370.00 |
| Previous Close | 6,400.00 |
| Day's Range | 6,370.00 - 6,580.00 |
| 52-Week Range | 4,820.00 - 6,820.00 |
| Beta | 0.44 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 20, 2026 |